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INTRODUCTION:
CVST is a distinct cerebrovascular disorder that most 
commonly affect young adults and children. 1,2 It has a 
strong female preponderance with female to male ratio 
of 3:1.3,4,5 It is less common than arterial stroke but 
with advancement of neuroimaging modalities it is 
being more frequently diagnosed. Due to its variable 
clinical spectrum its diagnosis is often challenging.3 
Annual incidence of CVST is 0.22-1.57/100,000 of 
population.3-6 The median age of patients presenting 
with CVST is 37 years.4 Raised intracranial pressure is 
a common complication of CVST, occurring more 
frequently if superior sagittal sinus (SSS) is involved.3 
Signs and symptoms of CVST are grouped into three 
major syndromes:
1.Isolated intracranial hypertension syndrome (IIHS), 
consisting of headache with or without vomiting,     
papilledema and visual disturbance.7
2.Focal syndrome (focal deficits, seizures, or both)3.
3.Encephalopathy (multifocal signs, mental status 
changes, stupor or coma)6.
With SSS thrombosis motor deficit, bilateral deficit and 
seizures are frequent, however; IIHS is infrequent.3
We report a case of CVST with unusual presentation of 
quadriparesis and visual loss in whom SSS thrombosis 
presented unusually with features of IIHS.
CASE REPORT:
We report the case of a 16 year old female, who 
presented with headache for 2 months, episodic, 
involving the whole head, throbbing in character with no 
other associated feature and relieved with analgesics. 
This was followed by 10 days history of acute onset non 
progressive, painless, symmetrical quadriparesis and 4 
days history of bilateral visual loss. There was no past 
medical history of drug use, upper respiratory tract 
infection, vomiting, diarrhea, fever, seizures or 
sphincter involvement while gynecological history was 
normal. Patient had a Body Mass Index (BMI) of 33.09 
kg/m2. She has pallor of conjunctiva, with stable vitals 
and Glasgow coma scale (GCS) of 15/15. She had no 
perception of light bilaterally and pupils were dilated 
and non-reactive to light. Fundus examination showed 
bilateral papilledema with hemorrhages. She had left 6th nerve palsy. Sensory system examination was normal. Motor 
system examination showed normal tone, power of 4/5 in all four limb, reflexes were grade 2 and plantars were 
bilaterally extensor. Functional mobility scale (FMS) was 3. Important differential diagnosis were multiple sclerosis and 
NMOSD. Blood complete picture showed Hb: 5.3, MCV 69. Serum peripheral film showed microcytic hypochromic red 
cells with Hemoglobin electrophoresis was normal.
Lumbar puncture was done and showed CSF opening pressure of 72 cm of water. 20 ml of CSF was drained. CSF 
routine examination was normal. CSF for oligoclonal bands was negative. Anti-NMO antibodies were negative. Thyroid 
function tests were normal. CT scan brain was normal.
MRI brain and orbit showed left transverse and superior sagittal sinus flow void signals while MR Venography (MRV) 
revealed superior sagittal sinus thrombosis (fig 1 and 2). CSF opening pressure checked after 3 days showed opening 
pressure of 35 cm of water. Injection  Methylprednisolone 1 gm once daily was given for 3 days, acetazolamide 500 
mg twice daily and injection Enoxaprin 1mg/kg twice a day subcutaneously, later shifted to tablet Rivaroxaban. 2 pints 
of  Red cell concentrates were transfused. Ventriculoperitoneal shunting was planned. Visual acuity improved to 
perception of moving fingers and FMS was 1.
DISCUSSION:
CVST is a multicausal disorder that affects the venous part of neurovascular system. The incidence, clinical 
presentations, imaging and outcome are variable. Various risk factors are associated with different age groups.8,9,10,11,12 
Risk factors associated with CVST are numerated in table 1.8
Table 1. Risk Factors for CVST
However 20% of cases do not show any known risk factors.11,12,13,14 The risk of CVST is increased 20 folds in females 
with inherited disorder of hemostatic system who are using contraception.13 Pregnancy and puerperium causes a 
fourfold increase in the risk of venous thrombosis. Females below the age of 40 years have a twofold higher risk of 
having venous thrombosis as compared to arterial infarcts.14
With increased awareness and advancement of diagnostic tools CVST is more frequently diagnosed.14 Clinical 
presentations of CVST are in table 2. Headache is the most common presenting symptom in CVST. 14
Anemia is not very uncommon in CVST. 76 % of female patients with CVST has anemia and 66% of them had 
microcytic hypochromic anemia.15 In our case patient had microcytic hypochromic anemia which also contributed to 
development of CVST.
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Table 2. Clinical Presentation of CVST
A rare syndrome is described comprising of blindness, ophthalmoplegia and extensive radiculopathy in 2 patients of 
CVST and cause in them was raised ICP.16,17 Bilateral motor weakness is common with SSS thrombosis. Both clinical 
features, i.e. visual impairment and bilateral motor weakness are present in our patient which is a rare presentation of 
CVST. Cerebral venous sinus thrombosis is treatable disease, with prompt diagnosis and treatment, risk of 
complications and disability can be reduced.
Figure 1. MRI brain plain FLAIR images. A and B show 
coronal (A) and axial images (B) with hyper intense signals 
within superior sagittal, left transverse and sigmoid sinuses 
Figure 2. MRV brain. 
MRV shows signal void in superior sagittal sinus, left 
transverse and sigmoid sinuses, suggestive of superior 
sagittal sinus, left transverse and sigmoid sinuses 
thrombosis.
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ABSTRACT:
We report case of a 16 year old girl with no known co-morbidities, presented with headache, quadriparesis and sudden 
vision loss. She had pallor and BMI was 33.09kg/m2. She had left 6th nerve palsy, bilateral papilledema and no 
perception of light. Motor examination showed power of 4/5 in all four limbs with bilateral extensor plantars. 
Neuroimaging was suggestive of superior saggital sinus thrombosis. CSF opening pressure was 72 cm of water.20 ml 
CSF was drained leading to improvement in headache and visual acuity. CVST presenting with quadriparesis and visual 
loss is a rare entity. Common presentations of CVST include headache, seizures, focal neurological deficit and altered 
conscious level. In our case risk factors for CVST like anemia and high body mass index (BMI) were present, but 
presenting clinical features were unusual. CVST is treatable so early diagnosis and knowledge of whole spectrum of 
clinical presentation is of extreme importance.
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INTRODUCTION:
CVST is a distinct cerebrovascular disorder that most 
commonly affect young adults and children. 1,2 It has a 
strong female preponderance with female to male ratio 
of 3:1.3,4,5 It is less common than arterial stroke but 
with advancement of neuroimaging modalities it is 
being more frequently diagnosed. Due to its variable 
clinical spectrum its diagnosis is often challenging.3 
Annual incidence of CVST is 0.22-1.57/100,000 of 
population.3-6 The median age of patients presenting 
with CVST is 37 years.4 Raised intracranial pressure is 
a common complication of CVST, occurring more 
frequently if superior sagittal sinus (SSS) is involved.3 
Signs and symptoms of CVST are grouped into three 
major syndromes:
1.Isolated intracranial hypertension syndrome (IIHS), 
consisting of headache with or without vomiting,     
papilledema and visual disturbance.7
2.Focal syndrome (focal deficits, seizures, or both)3.
3.Encephalopathy (multifocal signs, mental status 
changes, stupor or coma)6.
With SSS thrombosis motor deficit, bilateral deficit and 
seizures are frequent, however; IIHS is infrequent.3
We report a case of CVST with unusual presentation of 
quadriparesis and visual loss in whom SSS thrombosis 
presented unusually with features of IIHS.
CASE REPORT:
We report the case of a 16 year old female, who 
presented with headache for 2 months, episodic, 
involving the whole head, throbbing in character with no 
other associated feature and relieved with analgesics. 
This was followed by 10 days history of acute onset non 
progressive, painless, symmetrical quadriparesis and 4 
days history of bilateral visual loss. There was no past 
medical history of drug use, upper respiratory tract 
infection, vomiting, diarrhea, fever, seizures or 
sphincter involvement while gynecological history was 
normal. Patient had a Body Mass Index (BMI) of 33.09 
kg/m2. She has pallor of conjunctiva, with stable vitals 
and Glasgow coma scale (GCS) of 15/15. She had no 
perception of light bilaterally and pupils were dilated 
and non-reactive to light. Fundus examination showed 
bilateral papilledema with hemorrhages. She had left 6th nerve palsy. Sensory system examination was normal. Motor 
system examination showed normal tone, power of 4/5 in all four limb, reflexes were grade 2 and plantars were 
bilaterally extensor. Functional mobility scale (FMS) was 3. Important differential diagnosis were multiple sclerosis and 
NMOSD. Blood complete picture showed Hb: 5.3, MCV 69. Serum peripheral film showed microcytic hypochromic red 
cells with Hemoglobin electrophoresis was normal.
Lumbar puncture was done and showed CSF opening pressure of 72 cm of water. 20 ml of CSF was drained. CSF 
routine examination was normal. CSF for oligoclonal bands was negative. Anti-NMO antibodies were negative. Thyroid 
function tests were normal. CT scan brain was normal.
MRI brain and orbit showed left transverse and superior sagittal sinus flow void signals while MR Venography (MRV) 
revealed superior sagittal sinus thrombosis (fig 1 and 2). CSF opening pressure checked after 3 days showed opening 
pressure of 35 cm of water. Injection  Methylprednisolone 1 gm once daily was given for 3 days, acetazolamide 500 
mg twice daily and injection Enoxaprin 1mg/kg twice a day subcutaneously, later shifted to tablet Rivaroxaban. 2 pints 
of  Red cell concentrates were transfused. Ventriculoperitoneal shunting was planned. Visual acuity improved to 
perception of moving fingers and FMS was 1.
DISCUSSION:
CVST is a multicausal disorder that affects the venous part of neurovascular system. The incidence, clinical 
presentations, imaging and outcome are variable. Various risk factors are associated with different age groups.8,9,10,11,12 
Risk factors associated with CVST are numerated in table 1.8
Table 1. Risk Factors for CVST
However 20% of cases do not show any known risk factors.11,12,13,14 The risk of CVST is increased 20 folds in females 
with inherited disorder of hemostatic system who are using contraception.13 Pregnancy and puerperium causes a 
fourfold increase in the risk of venous thrombosis. Females below the age of 40 years have a twofold higher risk of 
having venous thrombosis as compared to arterial infarcts.14
With increased awareness and advancement of diagnostic tools CVST is more frequently diagnosed.14 Clinical 
presentations of CVST are in table 2. Headache is the most common presenting symptom in CVST. 14
Anemia is not very uncommon in CVST. 76 % of female patients with CVST has anemia and 66% of them had 
microcytic hypochromic anemia.15 In our case patient had microcytic hypochromic anemia which also contributed to 
development of CVST.
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INFECTIONS ) sinusitis
) Central nervous system infections
TRAUMA ) Head injury
OTHER MEDICAL 
CONDITIONS 
) Dehydration
) Pregnancy related
) Hematologic disorders: Polycythemia, sickle cell disease, 
Thrombotic thrombocytopenic purpura, Polycythemia, 
Paroxysmal nocturnal hemoglobinuria
) Hereditary thrombophilia
) Collagen vascular disorders
MEDICATION ) Oral contraceptive medications 
Table 2. Clinical Presentation of CVST
A rare syndrome is described comprising of blindness, ophthalmoplegia and extensive radiculopathy in 2 patients of 
CVST and cause in them was raised ICP.16,17 Bilateral motor weakness is common with SSS thrombosis. Both clinical 
features, i.e. visual impairment and bilateral motor weakness are present in our patient which is a rare presentation of 
CVST. Cerebral venous sinus thrombosis is treatable disease, with prompt diagnosis and treatment, risk of 
complications and disability can be reduced.
Figure 1. MRI brain plain FLAIR images. A and B show 
coronal (A) and axial images (B) with hyper intense signals 
within superior sagittal, left transverse and sigmoid sinuses 
Figure 2. MRV brain. 
MRV shows signal void in superior sagittal sinus, left 
transverse and sigmoid sinuses, suggestive of superior 
sagittal sinus, left transverse and sigmoid sinuses 
thrombosis.
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INTRODUCTION:
CVST is a distinct cerebrovascular disorder that most 
commonly affect young adults and children. 1,2 It has a 
strong female preponderance with female to male ratio 
of 3:1.3,4,5 It is less common than arterial stroke but 
with advancement of neuroimaging modalities it is 
being more frequently diagnosed. Due to its variable 
clinical spectrum its diagnosis is often challenging.3 
Annual incidence of CVST is 0.22-1.57/100,000 of 
population.3-6 The median age of patients presenting 
with CVST is 37 years.4 Raised intracranial pressure is 
a common complication of CVST, occurring more 
frequently if superior sagittal sinus (SSS) is involved.3 
Signs and symptoms of CVST are grouped into three 
major syndromes:
1.Isolated intracranial hypertension syndrome (IIHS), 
consisting of headache with or without vomiting,     
papilledema and visual disturbance.7
2.Focal syndrome (focal deficits, seizures, or both)3.
3.Encephalopathy (multifocal signs, mental status 
changes, stupor or coma)6.
With SSS thrombosis motor deficit, bilateral deficit and 
seizures are frequent, however; IIHS is infrequent.3
We report a case of CVST with unusual presentation of 
quadriparesis and visual loss in whom SSS thrombosis 
presented unusually with features of IIHS.
CASE REPORT:
We report the case of a 16 year old female, who 
presented with headache for 2 months, episodic, 
involving the whole head, throbbing in character with no 
other associated feature and relieved with analgesics. 
This was followed by 10 days history of acute onset non 
progressive, painless, symmetrical quadriparesis and 4 
days history of bilateral visual loss. There was no past 
medical history of drug use, upper respiratory tract 
infection, vomiting, diarrhea, fever, seizures or 
sphincter involvement while gynecological history was 
normal. Patient had a Body Mass Index (BMI) of 33.09 
kg/m2. She has pallor of conjunctiva, with stable vitals 
and Glasgow coma scale (GCS) of 15/15. She had no 
perception of light bilaterally and pupils were dilated 
and non-reactive to light. Fundus examination showed 
bilateral papilledema with hemorrhages. She had left 6th nerve palsy. Sensory system examination was normal. Motor 
system examination showed normal tone, power of 4/5 in all four limb, reflexes were grade 2 and plantars were 
bilaterally extensor. Functional mobility scale (FMS) was 3. Important differential diagnosis were multiple sclerosis and 
NMOSD. Blood complete picture showed Hb: 5.3, MCV 69. Serum peripheral film showed microcytic hypochromic red 
cells with Hemoglobin electrophoresis was normal.
Lumbar puncture was done and showed CSF opening pressure of 72 cm of water. 20 ml of CSF was drained. CSF 
routine examination was normal. CSF for oligoclonal bands was negative. Anti-NMO antibodies were negative. Thyroid 
function tests were normal. CT scan brain was normal.
MRI brain and orbit showed left transverse and superior sagittal sinus flow void signals while MR Venography (MRV) 
revealed superior sagittal sinus thrombosis (fig 1 and 2). CSF opening pressure checked after 3 days showed opening 
pressure of 35 cm of water. Injection  Methylprednisolone 1 gm once daily was given for 3 days, acetazolamide 500 
mg twice daily and injection Enoxaprin 1mg/kg twice a day subcutaneously, later shifted to tablet Rivaroxaban. 2 pints 
of  Red cell concentrates were transfused. Ventriculoperitoneal shunting was planned. Visual acuity improved to 
perception of moving fingers and FMS was 1.
DISCUSSION:
CVST is a multicausal disorder that affects the venous part of neurovascular system. The incidence, clinical 
presentations, imaging and outcome are variable. Various risk factors are associated with different age groups.8,9,10,11,12 
Risk factors associated with CVST are numerated in table 1.8
Table 1. Risk Factors for CVST
However 20% of cases do not show any known risk factors.11,12,13,14 The risk of CVST is increased 20 folds in females 
with inherited disorder of hemostatic system who are using contraception.13 Pregnancy and puerperium causes a 
fourfold increase in the risk of venous thrombosis. Females below the age of 40 years have a twofold higher risk of 
having venous thrombosis as compared to arterial infarcts.14
With increased awareness and advancement of diagnostic tools CVST is more frequently diagnosed.14 Clinical 
presentations of CVST are in table 2. Headache is the most common presenting symptom in CVST. 14
Anemia is not very uncommon in CVST. 76 % of female patients with CVST has anemia and 66% of them had 
microcytic hypochromic anemia.15 In our case patient had microcytic hypochromic anemia which also contributed to 
development of CVST.
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Table 2. Clinical Presentation of CVST
A rare syndrome is described comprising of blindness, ophthalmoplegia and extensive radiculopathy in 2 patients of 
CVST and cause in them was raised ICP.16,17 Bilateral motor weakness is common with SSS thrombosis. Both clinical 
features, i.e. visual impairment and bilateral motor weakness are present in our patient which is a rare presentation of 
CVST. Cerebral venous sinus thrombosis is treatable disease, with prompt diagnosis and treatment, risk of 
complications and disability can be reduced.
Figure 1. MRI brain plain FLAIR images. A and B show 
coronal (A) and axial images (B) with hyper intense signals 
within superior sagittal, left transverse and sigmoid sinuses 
Figure 2. MRV brain. 
MRV shows signal void in superior sagittal sinus, left 
transverse and sigmoid sinuses, suggestive of superior 
sagittal sinus, left transverse and sigmoid sinuses 
thrombosis.
Symptoms ) Headache
) Blurred vision
) Altered sensorium
) Nausea, vomiting
) Seizures
Signs ) Papilledema, 
) Focal neurologic deficit
) Cranial nerve palsies
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INTRODUCTION:
CVST is a distinct cerebrovascular disorder that most 
commonly affect young adults and children. 1,2 It has a 
strong female preponderance with female to male ratio 
of 3:1.3,4,5 It is less common than arterial stroke but 
with advancement of neuroimaging modalities it is 
being more frequently diagnosed. Due to its variable 
clinical spectrum its diagnosis is often challenging.3 
Annual incidence of CVST is 0.22-1.57/100,000 of 
population.3-6 The median age of patients presenting 
with CVST is 37 years.4 Raised intracranial pressure is 
a common complication of CVST, occurring more 
frequently if superior sagittal sinus (SSS) is involved.3 
Signs and symptoms of CVST are grouped into three 
major syndromes:
1.Isolated intracranial hypertension syndrome (IIHS), 
consisting of headache with or without vomiting,     
papilledema and visual disturbance.7
2.Focal syndrome (focal deficits, seizures, or both)3.
3.Encephalopathy (multifocal signs, mental status 
changes, stupor or coma)6.
With SSS thrombosis motor deficit, bilateral deficit and 
seizures are frequent, however; IIHS is infrequent.3
We report a case of CVST with unusual presentation of 
quadriparesis and visual loss in whom SSS thrombosis 
presented unusually with features of IIHS.
CASE REPORT:
We report the case of a 16 year old female, who 
presented with headache for 2 months, episodic, 
involving the whole head, throbbing in character with no 
other associated feature and relieved with analgesics. 
This was followed by 10 days history of acute onset non 
progressive, painless, symmetrical quadriparesis and 4 
days history of bilateral visual loss. There was no past 
medical history of drug use, upper respiratory tract 
infection, vomiting, diarrhea, fever, seizures or 
sphincter involvement while gynecological history was 
normal. Patient had a Body Mass Index (BMI) of 33.09 
kg/m2. She has pallor of conjunctiva, with stable vitals 
and Glasgow coma scale (GCS) of 15/15. She had no 
perception of light bilaterally and pupils were dilated 
and non-reactive to light. Fundus examination showed 
bilateral papilledema with hemorrhages. She had left 6th nerve palsy. Sensory system examination was normal. Motor 
system examination showed normal tone, power of 4/5 in all four limb, reflexes were grade 2 and plantars were 
bilaterally extensor. Functional mobility scale (FMS) was 3. Important differential diagnosis were multiple sclerosis and 
NMOSD. Blood complete picture showed Hb: 5.3, MCV 69. Serum peripheral film showed microcytic hypochromic red 
cells with Hemoglobin electrophoresis was normal.
Lumbar puncture was done and showed CSF opening pressure of 72 cm of water. 20 ml of CSF was drained. CSF 
routine examination was normal. CSF for oligoclonal bands was negative. Anti-NMO antibodies were negative. Thyroid 
function tests were normal. CT scan brain was normal.
MRI brain and orbit showed left transverse and superior sagittal sinus flow void signals while MR Venography (MRV) 
revealed superior sagittal sinus thrombosis (fig 1 and 2). CSF opening pressure checked after 3 days showed opening 
pressure of 35 cm of water. Injection  Methylprednisolone 1 gm once daily was given for 3 days, acetazolamide 500 
mg twice daily and injection Enoxaprin 1mg/kg twice a day subcutaneously, later shifted to tablet Rivaroxaban. 2 pints 
of  Red cell concentrates were transfused. Ventriculoperitoneal shunting was planned. Visual acuity improved to 
perception of moving fingers and FMS was 1.
DISCUSSION:
CVST is a multicausal disorder that affects the venous part of neurovascular system. The incidence, clinical 
presentations, imaging and outcome are variable. Various risk factors are associated with different age groups.8,9,10,11,12 
Risk factors associated with CVST are numerated in table 1.8
Table 1. Risk Factors for CVST
However 20% of cases do not show any known risk factors.11,12,13,14 The risk of CVST is increased 20 folds in females 
with inherited disorder of hemostatic system who are using contraception.13 Pregnancy and puerperium causes a 
fourfold increase in the risk of venous thrombosis. Females below the age of 40 years have a twofold higher risk of 
having venous thrombosis as compared to arterial infarcts.14
With increased awareness and advancement of diagnostic tools CVST is more frequently diagnosed.14 Clinical 
presentations of CVST are in table 2. Headache is the most common presenting symptom in CVST. 14
Anemia is not very uncommon in CVST. 76 % of female patients with CVST has anemia and 66% of them had 
microcytic hypochromic anemia.15 In our case patient had microcytic hypochromic anemia which also contributed to 
development of CVST.
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Table 2. Clinical Presentation of CVST
A rare syndrome is described comprising of blindness, ophthalmoplegia and extensive radiculopathy in 2 patients of 
CVST and cause in them was raised ICP.16,17 Bilateral motor weakness is common with SSS thrombosis. Both clinical 
features, i.e. visual impairment and bilateral motor weakness are present in our patient which is a rare presentation of 
CVST. Cerebral venous sinus thrombosis is treatable disease, with prompt diagnosis and treatment, risk of 
complications and disability can be reduced.
Figure 1. MRI brain plain FLAIR images. A and B show 
coronal (A) and axial images (B) with hyper intense signals 
within superior sagittal, left transverse and sigmoid sinuses 
Figure 2. MRV brain. 
MRV shows signal void in superior sagittal sinus, left 
transverse and sigmoid sinuses, suggestive of superior 
sagittal sinus, left transverse and sigmoid sinuses 
thrombosis.
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